Michael Douek, MD
Vascular & Interventional Radiology · Los Angeles, CANPI 1043253255
Payments from drug & device makers
What this record shows
This record is dominated by other: $42,532 of the $45,527 with a category attached, or 93.4%. Pulse Biosciences, Inc. accounts for 93.8% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $34,584, more than ten times the $101 reported in 2019.
Across 46 payments — averaging $989.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulse Biosciences, Inc.$43K
- Siemens Medical Solutions USA, Inc.$2K
- Johnson & Johnson$481
- Galvanize Therapeutics, Inc$319
- Angiodynamics, Inc.$143
- Trisalus Life Sciences, Inc.$73
- plus $101 from 2 others
What the payments were for
- Travel & lodging$1,1152%
- Food & beverage$1,8804%
- Other$42,53293%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulse Biosciences, Inc. | 7 | $42,698 |
| Siemens Medical Solutions USA, Inc. | 27 | $1,711 |
| Johnson & Johnson | 6 | $481 |
| Galvanize Therapeutics, Inc | 2 | $319 |
| Angiodynamics, Inc. | 1 | $143 |
| Trisalus Life Sciences, Inc. | 1 | $73 |
| Covidien LP | 1 | $65 |
| Biocompatibles, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CellFX$42,666
- Nanosecond Pulsed Field Ablation (nsPFA)$10,000
- MAGNETOM Vida$1,115
- ALIYA SYSTEM$319
- Neuwave$254
- Nanoknife$143
- Certus 140$100
How this compares
$45,527 in reported general payments places this provider in the 85th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Los Angeles
- Keith TerasakiLos Angeles$1.7M
- Edward LeeLos Angeles$1.4M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
- Navid EghbaliehLos Angeles$639K
- John MoriartyLos Angeles$527K
- Justin McWilliamsLos Angeles$265K
- Jessica StewartLos Angeles$254K
- Evan LehrmanLos Angeles$218K
- Steven RamanLos Angeles$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.